Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. It is caused by mutations in specific genes that are involved in the regulation of cholesterol metabolism. Understanding the genetics of HoFH is essential for accurate diagnosis, effective management, and genetic counseling. The…
***NOTE: The following article is not indexed in online search nor accessible to the public. It is solely intended as example content. Only users with access to this article’s link are able to access it.*** Juxtapid (lomitapide) is an approved medication that has shown significant promise in the treatment of Homozygous Familial Hypercholesterolemia (HoFH), a…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. Patient education is a vital component in the management of HoFH as it empowers individuals to understand their condition, make informed decisions, and actively participate in their treatment plan. In this article, we…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. Timely and accurate testing is essential for diagnosing HoFH and initiating appropriate management strategies. In this article, we will explore the various testing methods available for the detection of HoFH and their significance…
News Researchers Discover New Potential Treatment for Homozygous Familial Hypercholesterolemia Researchers Discover Novel Genetic Mutation Linked to Homozygous Familial Hypercholesterolemia FDA Grants Orphan Drug Designation to Promising HoFH Therapy Understanding the Link between Homozygous Familial Hypercholesterolemia and Other Comorbities Clinical Trial Shows Promising Results for HoFH Patients New Diagnostic Tool Offers Early Detection of Homozygous…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by significantly elevated levels of low-density lipoprotein cholesterol (LDL-C) in the blood. The condition poses serious cardiovascular risks and has the potential to impact life expectancy. However, with appropriate management and treatment, individuals with HoFH can lead fulfilling lives. HoFH is associated with a high…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare and challenging genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. The management of HoFH requires a comprehensive and multidisciplinary care team approach to provide personalized care and support to individuals with this condition. The HoFH care team consists of various healthcare…
***NOTE: The following article is not indexed in online search nor accessible to the public. It is solely intended as example content. Only users with access to this article’s link are able to access it.*** Evkeeza (evinacumab-dgnb) is a novel medication that has emerged as a promising treatment option for individuals with Homozygous Familial Hypercholesterolemia…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. The elevated cholesterol levels in HoFH can lead to the development of various comorbidities, which are additional health conditions that can occur alongside the primary disorder. In this article, we will explore some…
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. However, the diagnosis of HoFH can be challenging due to its similarities with other conditions that cause elevated cholesterol levels. In this article, we will discuss the differential diagnosis of HoFH and the…
